TD Cowen Reaffirms Their Buy Rating on HCA Healthcare (HCA)
TipRanks (Mon, 22-Jun 6:37 AM ET)
AI may help hospitals more than insurers, UBS says
Seeking Alpha News (Sun, 21-Jun 12:00 PM ET)
HCA Healthcare Announces Upcoming Chief Clinical Officer Transition
TipRanks (Thu, 18-Jun 9:31 AM ET)
HCA Healthcare Announces Agreement to Acquire The College of Health Care Professions
Business Wire (Wed, 27-May 4:30 PM ET)
HCA Colleagues Log 41,800 Volunteer Hours—Supporting 1,866 Nonprofits in Days of Service Initiative
Market Chameleon (Tue, 19-May 6:14 AM ET)
HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative
Business Wire (Tue, 19-May 8:30 AM ET)
HCA Healthcare, Inc. to Present at May Conference
Business Wire (Thu, 30-Apr 4:30 PM ET)
Business Wire (Mon, 27-Apr 5:00 PM ET)
HCA Announces Proposed Public Offering of Senior Notes
Business Wire (Mon, 27-Apr 8:24 AM ET)
HCA Healthcare Reports First Quarter 2026 Results
Business Wire (Fri, 24-Apr 7:00 AM ET)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
Hca Healthcare trades on the NYSE stock market under the symbol HCA.
As of June 22, 2026, HCA stock price climbed to $376.99 with 1,446,305 million shares trading.
HCA has a beta of 0.12, meaning it tends to be less sensitive to market movements. HCA has a correlation of 0.00 to the broad based SPY ETF.
HCA has a market cap of $83.63 billion. This is considered a Large Cap stock.
Last quarter Hca Healthcare reported $19 billion in Revenue and $7.15 earnings per share. This beat revenue expectation by $36 million and missed earnings estimates by -$.01.
In the last 3 years, HCA traded as high as $556.52 and as low as $215.96.
The top ETF exchange traded funds that HCA belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
HCA has underperformed the market in the last year with a return of +0.8%, while the SPY ETF gained +26.5%. In the last 3 month period, HCA fell short of the market, returning -24.8%, while SPY returned +13.1%. However, in the most recent 2 weeks HCA has outperformed the stock market by returning +4.4%, while SPY returned -1.4%.
HCA support price is $368.01 and resistance is $382.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCA shares will trade within this expected range on the day.